FindTrial
Sign In

Endoscopic ultrasonography-guided fine needle aspiration (EUS-FNA) and portal vein and hepatic vein circulation tumor cells (CTCs) detection for diagnosis of liver masses

Endoscopic ultrasonography-guided fine needle aspiration (EUS-FNA) and portal vein and hepatic vein circulation tumor cells (CTCs) detection for diagnosis of liver masses

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062488
Enrollment
Unknown
Registered
2022-08-09
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid hepatic masses

Interventions

Gold Standard:Based on the final diagnosis after clinical and pathological examination and postoperative follow-up.
Index test:Endoscopic&#32
ultrasonography-guided&#32
fine&#32
needle&#32
aspiration&#32
(EUS-FNA)&#32
and&#32
portal&#32
vein&#32
hepatic&#32
circulation&#32
tumor&#32
cells&#32
(CTCs)&#32
detection

Sponsors

Shengjing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Older than 18 years old; 2. US/CT/MRI showed the presence of a solid hepatic mass and the clinical need for preoperative puncture to clarify the diagnosis; 3. Good compliance.

Exclusion criteria

Exclusion criteria: 1. The patient has coagulation disorders; 2. The patient has severe cardiopulmonary disease, and other contraindications to endoscopy.

Design outcomes

Primary

MeasureTime frame
Circulation tumor cells in blood;Fine needle puncture tissues;—

Countries

China

Contacts

Public ContactGuo Jintao

Shengjing Hospital of China Medical University

guojt@sj-hospital.org+86 18940256654

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026